Synergy Pharma (SGYPQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -224,338 | -198,607 | -117,500 | -95,708 | -62,124 |
| Depreciation Amortization | 1,507 | 7,154 | 4,620 | 661 | 115 |
| Accounts receivable | -6,491 | 0 | 0 | N/A | N/A |
| Other Working Capital | -13,006 | 6,628 | 1,706 | 2,623 | 4,913 |
| Other Operating Activity | 29,439 | 55,072 | 10,185 | 3,360 | 4,465 |
| Operating Cash Flow | $-212,889 | $-129,753 | $-100,989 | $-89,064 | $-52,631 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 50,097 | -200 | N/A | -30,000 |
| PPE Investments | -210 | -297 | -50 | -173 | -615 |
| Other Investing Activity | 0 | 0 | 0 | 455 | -270 |
| Investing Cash Flow | $-210 | $49,800 | $-250 | $282 | $-30,885 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 95,140 | N/A | N/A | 200,000 | 0 |
| Common Stock Issued | 174,149 | 101,398 | 16,422 | 33,960 | 94,853 |
| Other Financing Activity | -1,591 | -711 | 0 | -16,838 | -5,623 |
| Financing Cash Flow | $267,698 | $100,687 | $16,422 | $217,122 | $89,230 |
| Beginning Cash Position | 82,387 | 61,653 | 146,470 | 18,130 | 12,416 |
| End Cash Position | 136,986 | 82,387 | 61,653 | 146,470 | 18,130 |
| Net Cash Flow | $54,599 | $20,734 | $-84,817 | $128,340 | $5,714 |
| Free Cash Flow | |||||
| Operating Cash Flow | -212,889 | -129,753 | -100,989 | -89,064 | -52,631 |
| Capital Expenditure | -210 | -297 | -50 | -173 | -615 |
| Free Cash Flow | -213,099 | -130,050 | -101,039 | -89,237 | -53,246 |